AB
Healthcare & Life Sciences
Algen Biotechnologies
United States
Algen Biotechnologies is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Algen Biotechnologies
Algen Biotechnologies is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Algen Biotechnologies uses CRISPR and machine learning to identify disease-driving RNA messages at single-cell resolution to discover therapeutics targeting cancer, inflammation, and other diseases with high unmet medical need.
Explore Algen Biotechnologies's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.